Of the millions of antibodies produced by the human immune system, Theraclone Sciences’ comprehensive screening technology rapidly identifies the rare few that have evolved to successfully ward off disease. We are working to develop these human monoclonal antibodies as safe and effective therapeutic products.
TypePrivate
HQSeattle, US
Founded2004
Size (employees)7 (est)-12%
Websitetheraclone-sciences.com
Theraclone Sciences was founded in 2004 and is headquartered in Seattle, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Theraclone Sciences

Clifford J. Stocks

Clifford J. Stocks

Chief Executive Officer & Board of Director
Kristine Swiderek

Kristine Swiderek

Chief Scientific Officer
Russ Hawkinson

Russ Hawkinson

Vice President, Chief Financial Officer
Steven Gillis

Steven Gillis

Executive Chairman and Acting President
Show more

Theraclone Sciences Office Locations

Theraclone Sciences has an office in Seattle
Seattle, US (HQ)
300 1124 Columbia St
Show all (1)
Report incorrect company information

Theraclone Sciences Financials and Metrics

Summary Metrics

Founding Date

2004

Theraclone Sciences total Funding

$58.2 m

Theraclone Sciences latest funding size

$3.08 m

Time since last funding

3 years ago

Theraclone Sciences investors

Theraclone Sciences's latest funding round in May 2015 was reported to be $3.1 m. In total, Theraclone Sciences has raised $58.2 m
Show all financial metrics
Report incorrect company information

Theraclone Sciences Company Life and Culture

Report incorrect company information